Thursday, November 7, 2024
I have been watching with great interest the successes and failures of different state and local coronavirus vaccination plans. I am struck by the inability to adjust to changing conditions brought on by a bureaucratic mindset. It varies greatly from the “flexibility is the key to air power” mindset that I formed in my days […]
With stock market valuations sitting near 20-year highs, investors are hoping corporate results and profit outlooks will help determine to what degree the valuations are justified. The catalyst that will drive the market to higher highs over the near-term will be the current fourth-quarter earnings season that will carry over into mid-February and a month […]
There have been several big movers in the stock market already in 2021. As expected, many of the highfliers from 2020—including stocks related to cryptocurrencies, electric vehicles, fuel cell technology, biotech, and others—continue to experience plenty of action. As anyone who’s traded in the market long enough knows, there’s almost always a hot investment. Maybe […]
Mobile video game maker Zynga (ZNGA) saw significant options activity last week. On a big volume day, ZNGA options traded 9x the normal options volume. 96% of the options action was in calls, which is generally a bullish sign. ZNGA has earnings on February 10th, and this could be a bet that the company is […]
For income investors, the last 11 months have been, to paraphrase Dickens, “the best of times, the worst of times.” The February-March 2020 market crash was especially brutal on the high-yield investment sectors. Without a lot of information, I had to analyze my Dividend Hunter recommendations and decide which were best to sell and which […]
To watch today’s Serge Berger Weekly options trade please click the video button.
Shares of Aclaris Therapeutics (ACRS) after announcing positive data from a Phase 2a trial of its rheumatoid arthritis treatment. “Aclaris Chief Medical Officer David Gordon said he believes the data supports the hypothesis that MK2 inhibition is an important novel target for treating immuno-inflammatory diseases, and he looks forward to progressing ATI-450 to Phase 2b,” […]
Every earnings season, I check the results from hundreds of publicly traded companies. In the past, for most companies, a quick scan of the earnings results would show whether or not a company remained on its expected trajectory. The 2020 fourth-quarter earnings results will be very different. They will tell the tale of a very […]
I make stock and options recommendations based on what the charts—not the talking heads and suit-and-ties on financial TV networks—tell me. I spend many hours every week analyzing stock charts, support and resistance levels, moving averages, and numerous other technical indicators of the major indices and stocks to ensure that I’m bringing you recommendations that […]
As popular as gold is as an investment, it’s not necessarily easy to pinpoint what type of investment gold is. Is it a safe-haven asset? A hedge against inflation? A currency? A store of value? Maybe it’s all of the above… The thing is, the type of investment gold is depends on the market environment […]
